The China Securities Regulatory Commission approved the IPO registration of GuRui Sr Technology on the Sci-Tech Innovation Board.
On September 4, the China Securities Regulatory Commission issued a reply regarding the approval of Guangdong Qirui Strontium CNC Technology Co., Ltd.'s initial public offering registration.
On September 4, the China Securities Regulatory Commission issued a reply regarding the approval of Guangdong Keri Stry Technology Co., Ltd.'s initial public offering registration. It is reported that Keri Stry plans to list on the Science and Technology Innovation Board of the Shanghai Stock Exchange, with Guotai Junan Securities as its sponsor, aiming to raise 719 million yuan.
According to the prospectus, Keri Stry mainly engages in the research and development, production, and sales of full direct-drive CNC machine tools and CNC systems, making it a leader in the domestic full direct-drive CNC machine tool market. It is one of the few companies in China that possesses both PWM-type CNC systems and bus-type CNC systems, both of which have achieved scale sales.
As of now, Keri Strys CNC system products have sold and been used in over 20,000 sets, applied in fields such as precision milling machines, precision grinding machines, five-axis linkage machine tools, three-dimensional five-axis lasers, force-controlled grinding equipment, and semi-automation equipment. They have effectively replaced mainstream CNC systems from brands like Siemens (Germany), Heidenhain (Germany), Fanuc (Japan), and Mitsubishi (Japan), gaining certain market recognition. Among them, the companys U series PWM-type CNC system has successfully broken the monopoly of Heidenhain in the Chinese machine tool market. In the domestic machine tool market, Heidenhain and the company are the main suppliers of PWM-type CNC systems. Additionally, the company's N series bus-type CNC system, due to its excellent performance and product stability, has been successfully sold to several globally renowned automation solution companies, such as Fanuc and Siasun Robot & Automation.
Related Articles

Guangdong Zhongsheng Pharmaceutical (002317.SZ): Fenofibrate capsules approved to increase the 0.2g specification.

COSMOS MACH (00118): Non-executive director Jian Weihua has passed away.

CGN NEW ENERGY (01811) spent HKD 963,500 to repurchase 462,000 shares on September 4.
Guangdong Zhongsheng Pharmaceutical (002317.SZ): Fenofibrate capsules approved to increase the 0.2g specification.

COSMOS MACH (00118): Non-executive director Jian Weihua has passed away.

CGN NEW ENERGY (01811) spent HKD 963,500 to repurchase 462,000 shares on September 4.

RECOMMEND





